Spinocerebellar Ataxia Type 37

Neurology·MeSH: Ataxia Telangiectasia

Prevalence

0.1 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Spinocerebellar Ataxia Type 37?

There are 1 clinical trial targeting Spinocerebellar Ataxia Type 37 tracked by BioSniper.

What is the prevalence of Spinocerebellar Ataxia Type 37?

The estimated prevalence of Spinocerebellar Ataxia Type 37 is approximately 0.1 per 100,000 population.

Deep-dive into Spinocerebellar Ataxia Type 37

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Spinocerebellar Ataxia Type 37 — Drugs in Development & Clinical Trials | BioSniper